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Introduction
The approach to and treatment of metabolic alkalosis
has made great strides in recent decades and molecular
mechanisms have been unraveled. Thus, we were
perplexed to receive a request for assistance with hydro-
chloric acid management. This treatment was not that
unusual in the distant past but is nowadays thankfully
uncommon.
A double-take is an expression of surprise in body
language. The consult request encompassed the title of
this report and elicited a double-take response in both of
us. We found the request a bit out of the ordinary and
hastened to our intensive care unit. Sometimes strange
requests turn out having a basis in fact. However, treating
the underlying disorder remains the best regimen for
ameliorating acid-base disturbances.
Case
The patient was a 50-year-old woman with terminal me-
tastatic cervical cancer. The tumour had infiltrated her
bladder, the ureters were obstructed bilaterally and the
large bowel was involved. Both ureters had been redir-
ected into an ileal conduit and a colostomy had been
placed. The patient was somnolent and could not give a
history. However, the nurses’ notes indicated profuse vo-
miting, anuria and now a steadily increasing creatinine
concentration. Her physicians were busy in the operating
room. However, the chart indicated the physicians’ order
for two ampules (40 mmol/ampule) of hydrochloric acid
to be infused in 500 mL Ringer’s acetate solution through
a central venous catheter. We also observed that the
patient was receiving a parenteral nutritional solution
(StructoKabiven®, Fresenius Kabi) supplying 1600 calories
per day in a volume of 1477 mL/24 h.
Physical examination disclosed blood pressure 90/60
mmHg, heart rate 90 b.p.m. and respiratory rate 8/min.
The patient could not be raised to a seated position
without fainting, the neck veins were entirely flat and no
hepato-jugular reflux could be elicited. The lungs were
clear and there were no murmurs or extra heart sounds.
She had no peripheral oedema. The sodium was 136,
potassium 2.7 and chloride 80 mmol/L. The creatinine
concentration was 434 µmol/L. The pH was 7.56, PaO2
64 mm Hg, PaCO2 53 mm Hg and HCO3 47 mmol/L.
Urinary electrolytes had not been monitored and her
anuria precluded our doing so.
We observed that StructoKabiven® is a remarkable
product with an excellent amino acid and caloric profile.
We were interested in the fact that the product she
received contained 157 mmol/L of acetate. The prep-
aration also contained sodium 60 mmol/L, potassium 45
mmol/L and chloride 52 mmol/L. We concluded that our
patient had an appropriately compensated metabolic
alkalosis, and so therefore recommended that the order
for hydrochloric acid infusion be discontinued and made
some alternative recommendations regarding her care.
Discussion
In patients with no kidney function, alkali addition gain
or acid losses increase serum bicarbonate levels, and the
excess alkali is retained until it is consumed eventually by
endogenous acid production [1]. When kidney function is
adequate, excess alkali is also excreted restoring serum
bicarbonate to normal levels. Particularly important in
that regard is the luminal Cl/HCO3
− exchanger, Pendrin.
Persistent alkalosis occurs only when tubular ion trans-
port is altered in a way that limits or prevents bicarbon-
ate excretion. Individuals receiving no chloride in the
diet, subjects undergoing gastric suction or patients suf-
fering from persistent vomiting develop metabolic alkalo-
sis, associated with excess acid and potassium excretion
into the urine. The disorder persists until chloride is given
to replete the losses that were induced. The overriding
role of chloride depletion, rather than volume contraction
per se, is outlined in detail elsewhere [2]. We initially be-
lieved that the clinical picture was complete, until we re-
viewed the contents of StructoKabiven®.
Acetate is a derivative of acetic acid. The term includes
salts and esters, as well as the anion found in solution.
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The acetate anion [CH3COO]− belongs to the carboxylate
family. Acetate is the conjugate base of acetic acid
(Figure 1) and is metabolized to CO2, H2O and HCO3
−
(CH3COO
−+ 2O2 = CO2 + H2O + HCO3
−) at a 1:1 ratio. Similar
to administration of bicarbonate, acetate can induce
metabolic alkalosis. Generally, metabolic alkalosis does
not occur with bicarbonate excretion because the capa-
bilities of excreting bicarbonate are substantial. However,
in patients with pre-existing chloride or potassium deple-
tion (both were present in our patient), alkali ingestion
results in a sustained increase in bicarbonate levels.
Finally, in patients with renal failure, administered alkali
is retained independent of body chloride or potassium
stores. In our patient, the anuria also eliminated her
ability to lose any bicarbonate in exchange for chloride,
via her ileal conduit.
Chloride repletion is a good idea. Although strategies
to deliver hydrochloric acid have been developed [3],
hydrochloric acid is unnecessary. The literature is replete
with therapeutic misadventures including breakdown of
pulmonary artery catheters, tissue and skin necrosis, and
erosion of recipient vessels [4, 5]. Normal saline, 4 L of
which can increase serum hydrogen ion concentration by
10 nmol/L [6, 7], and potassium chloride sufficed in our
patient, who unfortunately succumbed to her illness 10
days later. Our patient illustrated several aspects of
metabolic alkalosis simultaneously and taught us several
lessons, including the effects of chloride and potassium
depletion on key ion transporters, the physiological role
of Pendrin, the epithelial sodium channel, the H+-ATPase
and H+/K+-ATPase, stimulation of collecting duct ion
transport and effects of alkali administration.
Teaching points
(i) An acid-base disturbance is not a diagnosis. The di-
agnosis lies in identifying the underlying cause of the
disturbance.
(ii) Clinicians must know the contents of everything that
they prescribe their patients. Trade names of pro-
ducts, such as StructoKabiven®, is no substitute of
knowing the contents.
(iii) Hydrochloric acid has been infused therapeutically,
but only clinicians over 50 years of age would be
expected to know this.
(iv) An acid-base disturbance not uncommonly has more
than one mechanism, as was the case in this patient.
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Fig. 1. Acetate ion.
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